Table of Contents
Journal of Allergy
Volume 2011, Article ID 948406, 21 pages
http://dx.doi.org/10.1155/2011/948406
Review Article

Apoptosis and the Airway Epithelium

Section of Pulmonary and Critical Care Medicine, Department of Medicine, The University of Chicago, 5841 S. Maryland Avenue, MC 6076, Chicago, IL 60637, USA

Received 14 May 2011; Accepted 18 September 2011

Academic Editor: Darryl A. Knight

Copyright © 2011 Steven R. White. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. R. White and A. R. Leff, “Epithelium as a target,” in Inflammatory Mechanisms in Asthma, W. W. Busse and S. T. Holgate, Eds., pp. 497–536, Marcel Dekker, New York, NY, USA, 1998. View at Google Scholar
  2. C. Ordoñez, R. Ferrando, D. M. Hyde, H. H. Wong, and J. V. Fahy, “Epithelial desquamation in asthma: artifact or pathology?” American Journal of Respiratory and Critical Care Medicine, vol. 162, no. 6, pp. 2324–2329, 2000. View at Google Scholar · View at Scopus
  3. M. J. Whitcutt, K. B. Adler, and R. Wu, “A biphasic chamber system for maintaining polarity of differentiation of cultured respiratory tract epithelial cells,” In Vitro Cellular and Developmental Biology—Animal, vol. 24, no. 5, pp. 420–428, 1988. View at Google Scholar · View at Scopus
  4. K. B. Adler, P. W. Cheng, and K. C. Kim, “Characterization of guinea pig tracheal epithelial cells maintained in biphasic organotypic culture: cellular composition and biochemical analysis of released glycoconjugates,” American Journal of Respiratory Cell and Molecular Biology, vol. 2, no. 2, pp. 145–154, 1990. View at Google Scholar · View at Scopus
  5. D. C. Gruenert, C. B. Basbaum, M. J. Welsh, M. Li, W. E. Finkbeiner, and J. A. Nadel, “Characterization of human tracheal epithelial cells transformed by an origin-defective simian virus 40,” Proceedings of the National Academy of Sciences of the United States of America, vol. 85, no. 16, pp. 5951–5955, 1988. View at Google Scholar · View at Scopus
  6. D. C. Gruenert, W. E. Finkbeiner, and J. H. Widdicombe, “Culture and transformation of human airway epithelial cells,” American Journal of Physiology, vol. 268, no. 3, pp. L347–L360, 1995. View at Google Scholar · View at Scopus
  7. M. Lieber, B. Smith, A. Szakal, W. Nelson-Rees, and G. Todaro, “A continuous tumor cell line from a human lung carcinoma with properties of type II alveolar epithelial cells,” International Journal of Cancer, vol. 17, no. 1, pp. 62–70, 1976. View at Google Scholar · View at Scopus
  8. L. Galluzzi, S. A. Aaronson, J. Abrams et al., “Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes,” Cell Death and Differentiation, vol. 16, no. 8, pp. 1093–1107, 2009. View at Publisher · View at Google Scholar
  9. D. V. Krysko, T. V. Berghe, E. Parthoens, K. D'Herde, and P. Vandenabeele, “Methods for distinguishing apoptotic from necrotic cells and measuring their clearance,” Methods in Enzymology, vol. 442, pp. 307–341, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. D. L. Vaux and A. Strasser, “The molecular biology of apoptosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 6, pp. 2239–2244, 1996. View at Publisher · View at Google Scholar · View at Scopus
  11. D. R. Schultz and W. J. Harrington, “Apoptosis: programmed cell death at a molecular level,” Seminars in Arthritis and Rheumatism, vol. 32, no. 6, pp. 345–369, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. B. Zhivotovsky and S. Orrenius, “Cell death mechanisms: cross-talk and role in disease,” Experimental Cell Research, vol. 316, no. 8, pp. 1374–1383, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Strasser, L. O'Connor, and V. M. Dixit, “Apoptosis signaling,” Annual Review of Biochemistry, vol. 69, pp. 217–245, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. R. S. Hotchkiss, A. Strasser, J. E. McDunn, and P. E. Swanson, “Mechanisms of disease: cell death,” The New England Journal of Medicine, vol. 361, no. 16, pp. 1570–1583, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. C. D. Gregory and J. D. Pound, “Cell death in the neighbourhood: direct microenvironmental effects of apoptosis in normal and neoplastic tissues,” Journal of Pathology, vol. 223, no. 2, pp. 177–194, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. N. N. Danial and S. J. Korsmeyer, “Cell death: critical control points,” Cell, vol. 116, no. 2, pp. 205–219, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. A. H. Wyllie, ““Where, O death, is thy sting?” A brief review of apoptosis biology,” Molecular Neurobiology, vol. 42, no. 1, pp. 4–9, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Muzio, A. M. Chinnaiyan, F. C. Kischkel et al., “FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death—inducing signaling complex,” Cell, vol. 85, no. 6, pp. 817–827, 1996. View at Publisher · View at Google Scholar · View at Scopus
  19. J. P. Medema, C. Scaffidi, P. H. Krammer, and M. E. Peter, “Bcl-xL acts downstream of caspase-8 activation by the CD95 death-inducing signaling complex,” Journal of Biological Chemistry, vol. 273, no. 6, pp. 3388–3393, 1998. View at Publisher · View at Google Scholar · View at Scopus
  20. K. J. Hamann, D. R. Dorscheid, F. D. Ko et al., “Expression of Fas (CD95) and FasL (CD95L) in human airway epithelium,” American Journal of Respiratory Cell and Molecular Biology, vol. 19, no. 4, pp. 537–542, 1998. View at Google Scholar · View at Scopus
  21. R. Weinlich, T. Brunner, and G. P. Amarante-Mendes, “Control of death receptor ligand activity by posttranslational modifications,” Cellular and Molecular Life Sciences, vol. 67, no. 10, pp. 1631–1642, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Ashkenazi and V. M. Dixit, “Death receptors: signaling and modulation,” Science, vol. 281, no. 5381, pp. 1305–1308, 1998. View at Google Scholar · View at Scopus
  23. K. Newton, A. W. Harris, M. L. Bath, K. G. C. Smith, and A. Strasser, “A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes,” The EMBO Journal, vol. 17, no. 3, pp. 706–718, 1998. View at Publisher · View at Google Scholar · View at Scopus
  24. J. W. Yu and Y. Shi, “FLIP and the death effector domain family,” Oncogene, vol. 27, no. 48, pp. 6216–6227, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. J. J. Lemasters, “Dying a thousand deaths: redundant pathways from different organelles to apoptosis and necrosis,” Gastroenterology, vol. 129, no. 1, pp. 351–360, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. D. R. Green, “Apoptotic pathways: ten minutes to dead,” Cell, vol. 121, no. 5, pp. 671–674, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Lettau, M. Paulsen, D. Kabelitz, and O. Janssen, “FasL expression and reverse signalling,” Results and Problems in Cell Differentiation, vol. 49, pp. 49–61, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Tanaka, T. Suda, K. Haze et al., “Fas ligand in human serum,” Nature Medicine, vol. 2, no. 3, pp. 317–322, 1996. View at Publisher · View at Google Scholar · View at Scopus
  29. H. Matsuno, K. Yudoh, Y. Watanabe, F. Nakazawa, H. Aono, and T. Kimura, “Stromelysin-1 (MMP-3) in synovial fluid of patients with rheumatoid arthritis has potential to cleave membrane bound Fas ligand,” Journal of Rheumatology, vol. 28, no. 1, pp. 22–28, 2001. View at Google Scholar · View at Scopus
  30. M. F. Tosi, J. M. Stark, C. W. Smith, A. Hamedani, D. C. Gruenert, and M. D. Infeld, “Induction of ICAM-1 expression on human airway epithelial cells by inflammatory cytokines: effects on neutrophil-epithelial cell adhesion,” American Journal of Respiratory Cell and Molecular Biology, vol. 7, no. 2, pp. 214–221, 1992. View at Google Scholar · View at Scopus
  31. T. M. Krunkosky, B. M. Fischer, L. D. Martin, N. Jones, N. J. Akley, and K. B. Adler, “Effects of TNF-α on expression of ICAM-1 in human airway epithelial cells in vitro: signaling pathways controlling surface and gene expression,” American Journal of Respiratory Cell and Molecular Biology, vol. 22, no. 6, pp. 685–692, 2000. View at Google Scholar · View at Scopus
  32. H. Kim, J. S. Hwang, C. H. Woo et al., “TNF-α-induced up-regulation of intercellular adhesion molecule-1 is regulated by a Rac-ROS-dependent cascade in human airway epithelial cells,” Experimental and Molecular Medicine, vol. 40, no. 2, pp. 167–175, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Becker, H. S. Koren, and D. C. Henke, “Interleukin-8 expression in normal nasal epithelium and its modulation by infection with respiratory syncytial virus and cytokines tumor necrosis factor, interleukin-1, and interleukin-6,” American Journal of Respiratory Cell and Molecular Biology, vol. 8, no. 1, pp. 20–27, 1993. View at Google Scholar · View at Scopus
  34. T. Roger, P. Bresser, M. Snoek et al., “Exaggerated IL-8 and IL-6 responses to TNF-α by parainfluenza virus type 4-infected NCI-H292 cells,” American Journal of Physiology, vol. 287, no. 5, pp. L1048–L1055, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. S. J. Levine, P. Larivee, C. Logun, C. W. Angus, and J. H. Shelhamer, “Corticosteroids differentially regulate secretion of IL-6, IL-8, and G-CSF by a human bronchial epithelial cell line,” American Journal of Physiology, vol. 265, no. 4, pp. L360–L368, 1993. View at Google Scholar · View at Scopus
  36. L. A. Tartaglia and D. V. Goeddel, “Two TNF receptors,” Immunology Today, vol. 13, no. 5, pp. 151–153, 1992. View at Google Scholar · View at Scopus
  37. H. Hsu, J. Xiong, and D. V. Goeddel, “The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation,” Cell, vol. 81, no. 4, pp. 495–504, 1995. View at Google Scholar · View at Scopus
  38. D. J. van Antwerp, S. J. Martin, I. M. Verma, and D. R. Green, “Inhibition of TNF-induced apoptosis by NF-κB,” Trends in Cell Biology, vol. 8, no. 3, pp. 107–111, 1998. View at Publisher · View at Google Scholar · View at Scopus
  39. S. R. Wiley, K. Schooley, P. J. Smolak et al., “Identification and characterization of a new member of the TNF family that induces apoptosis,” Immunity, vol. 3, no. 6, pp. 673–682, 1995. View at Publisher · View at Google Scholar · View at Scopus
  40. I. Jeremias and K. M. Debatin, “TRAIL induces apoptosis and activation of NFκB,” European Cytokine Network, vol. 9, no. 4, pp. 687–688, 1998. View at Google Scholar · View at Scopus
  41. P. Schneider, M. Thome, K. Burns et al., “TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-κB,” Immunity, vol. 7, no. 6, pp. 831–836, 1997. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Erlacher, E. M. Michalak, P. N. Kelly et al., “BH3-only proteins Puma and Bim are rate-limiting for γ-radiation- and glucocorticoid-induced apoptosis of lymphoid cells in vivo,” Blood, vol. 106, no. 13, pp. 4131–4138, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. C. Scaffidi, S. Fulda, A. Srinivasan et al., “Two CD95 (APO-1/Fas) signaling pathways,” The EMBO Journal, vol. 17, no. 6, pp. 1675–1687, 1998. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Strasser, “The role of BH3-only proteins in the immune system,” Nature Reviews Immunology, vol. 5, no. 3, pp. 189–200, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. P. D. Zalewski and R. E. Ruffin, “Apoptosis-regulatory factors as potential drug targets in the epithelium of normal and inflamed airways,” Current molecular pharmacology, vol. 1, no. 1, pp. 38–49, 2008. View at Google Scholar · View at Scopus
  46. T. Kaufmann, L. Tai, P. G. Ekert et al., “The BH3-only protein bid is dispensable for DNA damage- and replicative stress-induced apoptosis or cell-cycle arrest,” Cell, vol. 129, no. 2, pp. 423–433, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. J. E. Chipuk and D. R. Green, “How do BCL-2 proteins induce mitochondrial outer membrane permeabilization?” Trends in Cell Biology, vol. 18, no. 4, pp. 157–164, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. T. Kuwana, L. Bouchier-Hayes, J. E. Chipuk et al., “BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly,” Molecular Cell, vol. 17, no. 4, pp. 525–535, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. S. N. Willis, J. I. Fletcher, T. Kaufmann et al., “Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak,” Science, vol. 315, no. 5813, pp. 856–859, 2007. View at Publisher · View at Google Scholar · View at Scopus
  50. D. R. Dorscheid, K. R. Wojcik, S. Sun, B. Marroquin, and S. R. White, “Apoptosis of airway epithelial cells induced by corticosteroids,” American Journal of Respiratory and Critical Care Medicine, vol. 164, no. 10, part 1, pp. 1939–1947, 2001. View at Google Scholar · View at Scopus
  51. S. R. White, P. Williams, K. R. Wojcik et al., “Initiation of apoptosis by actin cytoskeletal derangement in human airway epithelial cells,” American Journal of Respiratory Cell and Molecular Biology, vol. 24, no. 3, pp. 282–294, 2001. View at Google Scholar · View at Scopus
  52. I. Durieu, C. Amsellem, C. Paulin et al., “Fas and Fas ligand expression in cystic fibrosis airway epithelium,” Thorax, vol. 54, no. 12, pp. 1093–1098, 1999. View at Google Scholar · View at Scopus
  53. A. Trautmann, P. Schmid-Grendelmeier, K. Krüger et al., “T cells and eosinophils cooperate in the induction of bronchial epithelial cell apoptosis in asthma,” Journal of Allergy and Clinical Immunology, vol. 109, no. 2, pp. 329–337, 2002. View at Publisher · View at Google Scholar
  54. M. Nakamura, G. Matute-Bello, W. C. Liles et al., “Differential response of human lung epithelial cells to Fas-induced apoptosis,” American Journal of Pathology, vol. 164, no. 6, pp. 1949–1958, 2004. View at Google Scholar · View at Scopus
  55. A. Fine, N. L. Anderson, T. L. Rothstein, M. C. Williams, and B. R. Gochuico, “Fas expression in pulmonary alveolar type II cells,” American Journal of Physiology, vol. 273, no. 1, pp. L64–L71, 1997. View at Google Scholar · View at Scopus
  56. G. Matute-Bello, W. C. Liles, C. W. Frevert et al., “Recombinant human Fas ligand induces alveolar epithelial cell apoptosis and lung injury in rabbits,” American Journal of Physiology, vol. 281, no. 2, pp. L328–L335, 2001. View at Google Scholar · View at Scopus
  57. G. Matute-Bello, C. W. Frevert, W. C. Liles et al., “Fas/Fas ligand system mediates epithelial injury, but not pulmonary host defenses, in response to inhaled bacteria,” Infection and Immunity, vol. 69, no. 9, pp. 5768–5776, 2001. View at Publisher · View at Google Scholar · View at Scopus
  58. C. R. Smith, A. Jaramillo, B. F. Duffy, and T. Mohanakumar, “Airway epithelial cell damage mediated by antigen-specific T cells: implications in lung allograft rejection,” Human Immunology, vol. 61, no. 10, pp. 985–992, 2000. View at Publisher · View at Google Scholar · View at Scopus
  59. M. E. De Paepe, L. P. Rubin, C. Jude, A. M. Lesieur-Brooks, D. R. Mills, and F. I. Luks, “Fas ligand expression coincides with alveolar cell apoptosis in late-gestation fetal lung development,” American Journal of Physiology, vol. 279, no. 5, pp. L967–L976, 2000. View at Google Scholar · View at Scopus
  60. T. A. Ferguson and T. S. Griffith, “A vision of cell death: Fas ligand and immune privilege 10 years later,” Immunological Reviews, vol. 213, no. 1, pp. 228–238, 2006. View at Publisher · View at Google Scholar · View at Scopus
  61. A. Druilhe, B. Wallaert, A. Tsicopoulos et al., “Apoptosis, proliferation, and expression of Bcl-2, Fas, and Fas ligand in bronchial biopsies from asthmatics,” American Journal of Respiratory Cell and Molecular Biology, vol. 19, no. 5, pp. 747–757, 1998. View at Google Scholar · View at Scopus
  62. S. J. Wadsworth, R. Atsuta, J. O. McIntyre, T. L. Hackett, G. K. Singhera, and D. R. Dorscheid, “IL-13 and TH2 cytokine exposure triggers matrix metalloproteinase 7-mediated Fas ligand cleavage from bronchial epithelial cells,” Journal of Allergy and Clinical Immunology, vol. 126, no. 2, pp. 366–374, 2010. View at Publisher · View at Google Scholar · View at Scopus
  63. T. C. Polek, M. Talpaz, and T. Spivak-Kroizman, “The TNF receptor, RELT, binds SPAK and uses it to mediate p38 and JNK activation,” Biochemical and Biophysical Research Communications, vol. 343, no. 1, pp. 125–134, 2006. View at Publisher · View at Google Scholar · View at Scopus
  64. A. M. Chinnalyan, K. O'Rourke, M. Tewari, and V. M. Dixit, “FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis,” Cell, vol. 81, no. 4, pp. 505–512, 1995. View at Google Scholar · View at Scopus
  65. S. Mitola, V. Sorbello, E. Ponte et al., “Tumor necrosis factor-α in airway secretions from cystic fibrosis patients upregulate endothelial adhesion molecules and induce airway epithelial cell apoptosis: implications for cystic fibrosis lung disease,” International Journal of Immunopathology and Pharmacology, vol. 21, no. 4, pp. 851–865, 2008. View at Google Scholar
  66. L. Gallelli, G. Pelaia, D. Fratto et al., “Effects of budesonide on p38 MAPK activation, apoptosis and IL-8 secretion, induced by TNF-α and Haemophilus influenzae in human bronchial epithelial cells,” International Journal of Immunopathology and Pharmacology, vol. 23, no. 2, pp. 471–479, 2010. View at Google Scholar
  67. E. E. Varfolomeev and A. Ashkenazi, “Tumor necrosis factor: an apoptosis JuNKie?” Cell, vol. 116, no. 4, pp. 491–497, 2004. View at Publisher · View at Google Scholar · View at Scopus
  68. G. S. Pryhuber, H. L. Huyck, R. J. Staversky, J. N. Finkelstein, and M. A. O'Reilly, “Tumor necrosis factor-α-induced lung cell expression of antiapoptotic genes TRAF1 and cIAP2,” American Journal of Respiratory Cell and Molecular Biology, vol. 22, no. 2, pp. 150–156, 2000. View at Google Scholar · View at Scopus
  69. N. M. Robertson, J. G. Zangrilli, A. Steplewski et al., “Differential expression of TRAIL and TRAIL receptors in allergic asthmatics following segmental antigen challenge: evidence for a role of TRAIL in eosinophil survival,” Journal of Immunology, vol. 169, no. 10, pp. 5986–5996, 2002. View at Google Scholar · View at Scopus
  70. X. R. Zhang, L. Y. Zhang, S. Devadas, L. Li, A. D. Keegan, and Y. F. Shi, “Reciprocal expression of TRAIL and CD95L in Th1 and Th2 cells: role of apoptosis in T helper subset differentiation,” Cell Death and Differentiation, vol. 10, no. 2, pp. 203–210, 2003. View at Publisher · View at Google Scholar · View at Scopus
  71. G. K. Singhera, T. S. Chan, J. Y. Cheng, T. Z. Vitalis, K. J. Hamann, and D. R. Dorscheid, “Apoptosis of viral-infected airway epithelial cells limit viral production and is altered by corticosteroid exposure,” Respiratory Research, vol. 7, article no. 78, 2006. View at Publisher · View at Google Scholar · View at Scopus
  72. R. A. Bem, A. P. Bos, R. M. Wösten-van Asperen et al., “Potential role of soluble TRAIL in epithelial injury in children with severe RSV infection,” American Journal of Respiratory Cell and Molecular Biology, vol. 42, no. 6, pp. 697–705, 2010. View at Publisher · View at Google Scholar
  73. R. Breuer, G. Zajicek, T. G. Christensen, E. C. Lucey, and G. L. Snider, “Cell kinetics of normal adult hamster bronchial epithelium in the steady state,” American Journal of Respiratory Cell and Molecular Biology, vol. 2, no. 1, pp. 51–58, 1990. View at Google Scholar · View at Scopus
  74. M. M. Ayers and P. K. Jeffery, “Proliferation and differentiation in mammalian airway epithelium,” European Respiratory Journal, vol. 1, no. 1, pp. 58–80, 1988. View at Google Scholar · View at Scopus
  75. D. R. Dorscheid, E. Low, A. Conforti, S. Shifrin, A. I. Sperling, and S. R. White, “Corticosteroid-induced apoptosis in mouse airway epithelium: effect in normal airways and after allergen-induced airway inflammation,” Journal of Allergy and Clinical Immunology, vol. 111, no. 2, pp. 360–366, 2003. View at Publisher · View at Google Scholar · View at Scopus
  76. C. Zhou, G. Yin, J. Liu, X. Liu, and S. Zhao, “Epithelial apoptosis and loss in airways of children with asthma,” Journal of Asthma, vol. 48, no. 4, pp. 358–365, 2011. View at Publisher · View at Google Scholar
  77. A. M. Vignola, G. Chiappara, L. Siena et al., “Proliferation and activation of bronchial epithelial cells in corticosteroid-dependent asthma,” Journal of Allergy and Clinical Immunology, vol. 108, no. 5, pp. 738–746, 2001. View at Publisher · View at Google Scholar · View at Scopus
  78. H. Jyonouchi, “Airway epithelium and apoptosis,” Apoptosis, vol. 4, no. 6, pp. 407–417, 1999. View at Publisher · View at Google Scholar · View at Scopus
  79. P. J. Reddig and R. L. Juliano, “Clinging to life: cell to matrix adhesion and cell survival,” Cancer and Metastasis Reviews, vol. 24, no. 3, pp. 425–439, 2005. View at Publisher · View at Google Scholar · View at Scopus
  80. S. M. Puddicombe, R. Polosa, A. Richter et al., “Involvement of the epidermal growth factor receptor in epithelial repair in asthma,” The FASEB Journal, vol. 14, no. 10, pp. 1362–1374, 2000. View at Google Scholar · View at Scopus
  81. R. Polosa, S. M. Puddicombe, M. T. Krishna et al., “Expression of c-erbB receptors and ligands in the bronchial epithelium of asthmatic subjects,” Journal of Allergy and Clinical Immunology, vol. 109, no. 1, pp. 75–81, 2002. View at Publisher · View at Google Scholar · View at Scopus
  82. L. Chimenti, G. Morici, A. Paternò et al., “Bronchial epithelial damage after a half-marathon in nonasthmatic amateur runners,” American Journal of Physiology, vol. 298, no. 6, pp. L857–L862, 2010. View at Publisher · View at Google Scholar · View at Scopus
  83. O. Cohen, E. Feinstein, and A. Kimchi, “DAP-kinase is a Ca2+/calmodulin-dependent, cytoskeletal-associated protein kinase, with cell death-inducing functions that depend on its catalytic activity,” The EMBO Journal, vol. 16, no. 5, pp. 998–1008, 1997. View at Publisher · View at Google Scholar · View at Scopus
  84. O. Cohen, B. Inbal, J. L. Kissil et al., “DAP-kinase participates in TNF-α- and Fas-induced apoptosis and its function requires the death domain,” Journal of Cell Biology, vol. 146, no. 1, pp. 141–148, 1999. View at Publisher · View at Google Scholar · View at Scopus
  85. T. Raveh, G. Droguett, M. S. Horwitz, R. A. DePinho, and A. Kimchi, “DAP kinase activates a p19ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation,” Nature Cell Biology, vol. 3, no. 1, pp. 1–7, 2001. View at Publisher · View at Google Scholar · View at Scopus
  86. S. A. Belinsky, W. A. Palmisano, F. D. Gilliland et al., “Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers,” Cancer Research, vol. 62, no. 8, pp. 2370–2377, 2002. View at Google Scholar · View at Scopus
  87. P. M. Henson, D. L. Bratton, and V. A. Fadok, “The phosphatidylserine receptor: a crucial molecular switch?” Nature Reviews Molecular Cell Biology, vol. 2, no. 8, pp. 627–633, 2001. View at Publisher · View at Google Scholar · View at Scopus
  88. D. R. Green and H. M. Beere, “Apoptosis: gone but not forgotten,” Nature, vol. 405, no. 6782, pp. 28–29, 2000. View at Publisher · View at Google Scholar · View at Scopus
  89. L. Cohen, E. Xueping, J. Tarsi et al., “Epithelial cell proliferation contributes to airway remodeling in severe asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 176, no. 2, pp. 138–145, 2007. View at Publisher · View at Google Scholar · View at Scopus
  90. C. D. Gregory and J. D. Pound, “Microenvironmental influences of apoptosis in vivo and in vitro,” Apoptosis, vol. 15, no. 9, pp. 1029–1049, 2010. View at Publisher · View at Google Scholar · View at Scopus
  91. E. Lafont, D. Milhas, J. Teissié et al., “Caspase-10-dependent cell death in Fas/CD95 signalling is not abrogated by caspase inhibitor zVAD-fmk,” PLoS One, vol. 5, no. 10, Article ID e13638, 2010. View at Publisher · View at Google Scholar · View at Scopus
  92. Y. Qin, B. Camoretti-Mercado, L. Blokh, C. G. Long, F. D. Ko, and K. J. Hamann, “Fas resistance of leukemic eosinophils is due to activation of NF-κB by Fas ligation,” Journal of Immunology, vol. 169, no. 7, pp. 3536–3544, 2002. View at Google Scholar · View at Scopus
  93. H. Fluhr, S. Krenzer, G. M. Stein et al., “Interferon-γ and tumor necrosis factor-α sensitize primarily resistant human endometrial stromal cells to Fas-mediated apoptosis,” Journal of Cell Science, vol. 120, no. 23, pp. 4126–4133, 2007. View at Publisher · View at Google Scholar · View at Scopus
  94. M. S. Bharhani, R. Borojevic, S. Basak, E. Ho, P. Zhou, and K. Croitoru, “IL-10 protects mouse intestinal epithelial cells from Fas-induced apoptosis via modulating Fas expression and altering caspase-8 and FLIP expression,” American Journal of Physiology, vol. 291, no. 5, pp. G820–G829, 2006. View at Publisher · View at Google Scholar · View at Scopus
  95. A. Yokota, E. Takeuchi, M. Iizuka, Y. Ikegami, H. Takayama, and N. Shinohara, “Prominent dominant negative effect of a mutant Fas molecule lacking death domain on cell-mediated induction of apoptosis,” Molecular Immunology, vol. 42, no. 1, pp. 71–78, 2005. View at Publisher · View at Google Scholar · View at Scopus
  96. R. A. O'Donnell, A. Richter, J. Ward et al., “Expression of ErbB receptor and mucins in the airways of long term current smokers,” Thorax, vol. 59, no. 12, pp. 1032–1040, 2004. View at Publisher · View at Google Scholar · View at Scopus
  97. A. L. Innes, P. G. Woodruff, R. E. Ferrando et al., “Epithelial mucin stores are increased in the large airways of smokers with airflow obstruction,” Chest, vol. 130, no. 4, pp. 1102–1108, 2006. View at Publisher · View at Google Scholar · View at Scopus
  98. J. V. Fahy, “Remodeling of the airway epithelium in asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 164, no. 10, pp. S46–51, 2001. View at Google Scholar · View at Scopus
  99. H. C. Atherton, G. Jones, and H. Danahay, “IL-13-induced changes in the goblet cell density of human bronchial epithelial cell cultures: MAP kinase and phosphatidylinositol 3-kinase regulation,” American Journal of Physiology, vol. 285, no. 3, pp. L730–L739, 2003. View at Google Scholar · View at Scopus
  100. C. M. Evans, O. W. Williams, M. J. Tuvim et al., “Mucin is produced by clara cells in the proximal airways of antigen-challenged mice,” American Journal of Respiratory Cell and Molecular Biology, vol. 31, no. 4, pp. 382–394, 2004. View at Publisher · View at Google Scholar · View at Scopus
  101. S. M. Lankford, M. Macchione, A. L. Crews, S. A. Mckane, N. J. Akley, and L. D. Martin, “Modeling the airway epithelium in allergic asthma: interleukin-13-induced effects in differentiated murine tracheal epithelial cells,” In Vitro Cellular and Developmental Biology—Animal, vol. 41, no. 7, pp. 217–224, 2005. View at Publisher · View at Google Scholar · View at Scopus
  102. N. K. Malavia, J. D. Mih, C. B. Raub, B. T. Dinh, and S. C. George, “IL-13 induces a bronchial epithelial phenotype that is profibrotic,” Respiratory Research, vol. 9, p. 27, 2008. View at Google Scholar · View at Scopus
  103. H. K. Cheol, K. E. Kim, J. H. Yoon, and S. S. Kyoung, “Upregulation of MUC5AC gene expression by IL-4 through CREB in human airway epithelial cells,” Journal of Cellular Biochemistry, vol. 108, no. 4, pp. 974–981, 2009. View at Publisher · View at Google Scholar · View at Scopus
  104. K. Dabbagh, K. Takeyama, H. M. Lee, I. F. Ueki, J. A. Lausier, and J. A. Nadel, “IL-4 induces mucin gene expression and goblet cell metaplasia in vitro and in vivo,” Journal of Immunology, vol. 162, no. 10, pp. 6233–6237, 1999. View at Google Scholar · View at Scopus
  105. J. Turner, J. Roger, J. Fitau et al., “Goblet cells are derived from a FOXJ1-expressing progenitor in a human airway epithelium,” American Journal of Respiratory Cell and Molecular Biology, vol. 44, no. 3, pp. 276–284, 2011. View at Publisher · View at Google Scholar
  106. K. S. Park, J. M. Wells, A. M. Zorn et al., “Transdifferentiation of ciliated cells during repair of the respiratory epithelium,” American Journal of Respiratory Cell and Molecular Biology, vol. 34, no. 2, pp. 151–157, 2006. View at Publisher · View at Google Scholar · View at Scopus
  107. J. H. Kim, S. Y. Lee, S. M. Bak et al., “Effects of matrix metalloproteinase inhibitor on LPS-induced goblet cell metaplasia,” American Journal of Physiology, vol. 287, no. 1, pp. L127–L133, 2004. View at Publisher · View at Google Scholar · View at Scopus
  108. Y. Tesfaigzi, J. F. Harris, J. A. Hotchkiss, and J. R. Harkema, “DNA synthesis and Bcl-2 expression during development of mucous cell metaplasia in airway epithelium of rats exposed to LPS,” American Journal of Physiology, vol. 286, no. 2, pp. L268–L274, 2004. View at Google Scholar · View at Scopus
  109. L. E. Haswell, K. Hewitt, D. Thorne, A. Richter, and M. D. Gaça, “Cigarette smoke total particulate matter increases mucous secreting cell numbers in vitro: a potential model of goblet cell hyperplasia,” Toxicology in Vitro, vol. 24, no. 3, pp. 981–987, 2010. View at Publisher · View at Google Scholar · View at Scopus
  110. J. F. Harris, M. J. Fischer, J. R. Hotchkiss et al., “Bcl-2 sustains increased mucous and epithelial cell numbers in metaplastic airway epithelium,” American Journal of Respiratory and Critical Care Medicine, vol. 171, no. 7, pp. 764–772, 2005. View at Publisher · View at Google Scholar
  111. Y. Tesfaigzi, M. J. Fischer, A. J. Martin, and J. Seagrave, “Bcl-2 in LPS- and allergen-induced hyperplastic mucous cells in airway epithelia of Brown Norway rats,” American Journal of Physiology, vol. 279, no. 6, pp. L1210–L1217, 2000. View at Google Scholar · View at Scopus
  112. D. I. Blyth, M. S. Pedrick, T. J. Savage, H. Bright, J. E. Beesley, and S. Sanjar, “Induction, duration, and resolution of airway goblet cell hyperplasia in a murine model of atopic asthma: effect of concurrent infection with respiratory syncytial virus and response to dexamethasone,” American Journal of Respiratory Cell and Molecular Biology, vol. 19, no. 1, pp. 38–54, 1998. View at Google Scholar
  113. Z. O. Q. Shi, M. J. Fischer, G. T. De Sanctis, M. R. Schuyler, and Y. Tesfaigzi, “IFN-γ, but not fas, mediates reduction of allergen-induced mucous cell metaplasia by inducing apoptosis,” Journal of Immunology, vol. 168, no. 9, pp. 4764–4771, 2002. View at Google Scholar · View at Scopus
  114. J. Tesfaigzi, J. A. Hotchkiss, and J. R. Harkema, “Expression of the Bcl-2 protein in nasal epithelia of F344/N rats during mucous cell metaplasia and remodeling,” American Journal of Respiratory Cell and Molecular Biology, vol. 18, no. 6, pp. 794–799, 1998. View at Google Scholar · View at Scopus
  115. H. Zha, C. Aimé-Sempé, T. Sato, and J. C. Reed, “Proapoptotic protein Bax heterodimerizes with Bcl-2 and homodimerizes with Bax via a novel domain (BH3) distinct from BH1 and BH2,” Journal of Biological Chemistry, vol. 271, no. 13, pp. 7440–7444, 1996. View at Publisher · View at Google Scholar · View at Scopus
  116. Y. Tesfaigzi, M. J. Fischer, M. Daheshia, F. H. Y. Green, G. T. De Sanctis, and J. A. Wilder, “Bax is crucial for IFN-γ-induced resolution of allergen-induced mucus cell metaplasia,” Journal of Immunology, vol. 169, no. 10, pp. 5919–5925, 2002. View at Google Scholar · View at Scopus
  117. K. Takeyama, J. Tamaoki, M. Kondo, K. Isono, and A. Nagai, “Role of epidermal growth factor receptor in maintaining airway goblet cell hyperplasia in rats sensitized to allergen,” Clinical and Experimental Allergy, vol. 38, no. 5, pp. 857–865, 2008. View at Publisher · View at Google Scholar · View at Scopus
  118. J. W. Tyner, E. Y. Kim, K. Ide et al., “Blocking airway mucous cell metaplasia by inhibiting EGFR antiapoptosis and IL-13 transdifferentiation signals,” Journal of Clinical Investigation, vol. 116, no. 2, pp. 309–321, 2006. View at Publisher · View at Google Scholar · View at Scopus
  119. A. Sakula, “Henry Hyde Salter (1823-71): a biographical sketch,” Thorax, vol. 40, no. 12, pp. 887–888, 1985. View at Google Scholar · View at Scopus
  120. W. Osler, The Principles and Pracice of Medicine, D. Appleton and Company, New York, NY, USA, 1st edition, 1892.
  121. S. T. Holgate, “Pathogenesis of asthma,” Clinical & Experimental Allergy, vol. 38, no. 6, pp. 872–897, 2008. View at Google Scholar
  122. A. Chetta, A. Foresi, M. Del Donno, G. Bertorelli, A. Pesci, and D. Olivieri, “Airways remodeling is a distinctive feature of asthma and is related to severity of disease,” Chest, vol. 111, no. 4, pp. 852–857, 1997. View at Google Scholar · View at Scopus
  123. L. A. Laitinen, M. Heino, and A. Laitinen, “Damage of the airway epithelium and bronchial reactivity in patients with asthma,” American Review of Respiratory Disease, vol. 131, no. 4, pp. 599–606, 1985. View at Google Scholar
  124. R. Beasley, W. R. Roche, J. A. Roberts, and S. T. Holgate, “Cellular events in the bronchi in mild asthma and after bronchial provocation,” American Review of Respiratory Disease, vol. 139, no. 3, pp. 806–817, 1989. View at Google Scholar · View at Scopus
  125. P. K. Jeffery, A. J. Wardlaw, F. C. Nelson, J. V. Collins, and A. B. Kay, “Bronchial biopsies in asthma. An ultrastructural, quantitative study and correlation with hyperreactivity,” American Review of Respiratory Disease, vol. 140, no. 6, pp. 1745–1753, 1989. View at Google Scholar · View at Scopus
  126. L. A. Laitinen, A. Laitinen, and T. Haahtela, “Airway mucosal inflammation even in patients with newly diagnosed asthma,” American Review of Respiratory Disease, vol. 147, no. 3, pp. 697–704, 1993. View at Google Scholar · View at Scopus
  127. A. J. Polito and D. Proud, “Epithelial cells as regulators of airway inflammation,” Journal of Allergy and Clinical Immunology, vol. 102, no. 5, pp. 714–718, 1998. View at Google Scholar
  128. S. T. Holgate, P. Lackie, S. Wilson, W. Roche, and D. Davies, “Bronchial epithelium as a key regulator of airway allergen sensitization and remodeling in asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 162, no. 3, part 2, pp. S113–S117, 2000. View at Google Scholar · View at Scopus
  129. S. T. Holgate, D. E. Davies, S. Puddicombe et al., “Mechanisms of airway epithelial damage: epithelial-mesenchymal interactions in the pathogenesis of asthma,” European Respiratory Journal, Supplement, vol. 22, no. 44, pp. 24s–29s, 2003. View at Google Scholar
  130. S. T. Holgate, D. E. Davies, P. M. Lackie, S. J. Wilson, S. M. Puddicombe, and J. L. Lordan, “Epithelial-mesenchymal interactions in the pathogenesis of asthma,” Journal of Allergy and Clinical Immunology, vol. 105, no. 2, part 1, pp. 193–204, 2000. View at Google Scholar · View at Scopus
  131. Y. Morishima, A. Nomura, Y. Uchida et al., “Triggering the induction of myofibroblast and fibrogenesis by airway epithelial shedding,” American Journal of Respiratory Cell and Molecular Biology, vol. 24, no. 1, pp. 1–11, 2001. View at Google Scholar
  132. M. M. J. Chang, R. Wu, C. G. Plopper, and D. M. Hyde, “IL-8 is one of the major chemokines produced by monkey airway epithelium after ozone-induced injury,” American Journal of Physiology, vol. 275, no. 3, pp. L524–L532, 1998. View at Google Scholar · View at Scopus
  133. S. Ying, D. S. Robinson, Q. Meng et al., “Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial epithelial and endothelial cells,” European Journal of Immunology, vol. 27, no. 12, pp. 3507–3516, 1997. View at Publisher · View at Google Scholar
  134. J. Bousquet, P. K. Jeffery, W. W. Busse, M. Johnson, and A. M. Vignola, “Asthma: from bronchoconstriction to airways inflammation and remodeling,” American Journal of Respiratory and Critical Care Medicine, vol. 161, no. 5, pp. 1720–1745, 2000. View at Google Scholar
  135. A. M. Vignola, P. Chanez, A. M. Campbell et al., “Airway inflammation in mild intermittent and in persistent asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 157, no. 2, pp. 403–409, 1998. View at Google Scholar · View at Scopus
  136. P. J. Barnes and S. Pedersen, “Efficacy and safety of inhaled corticosteroids in asthma,” American Review of Respiratory Disease, vol. 148, no. 4, part 2, pp. S1–S26, 1993. View at Google Scholar
  137. M. J. Zitt, “Advances in inhaled corticosteroid pharmacology,” Allergy and Asthma Proceedings, vol. 28, no. 2, pp. 114–124, 2007. View at Publisher · View at Google Scholar · View at Scopus
  138. L. Zhang, I. Axelsson, M. Chung, and J. Lau, “Dose response of inhaled corticosteroids in children with persistent asthma: a systematic review,” Pediatrics, vol. 127, no. 1, pp. 129–138, 2011. View at Publisher · View at Google Scholar · View at Scopus
  139. C. S. Murray, “Can inhaled corticosteroids influence the natural history of asthma?” Current Opinion in Allergy and Clinical Immunology, vol. 8, no. 1, pp. 77–81, 2008. View at Publisher · View at Google Scholar · View at Scopus
  140. J. R. Johnson, S. R. Pacitto, J. Wong et al., “Combined budesonide/formoterol therapy in conjunction with allergen avoidance ameliorates house dust mite-induced airway remodeling and dysfunction,” American Journal of Physiology, vol. 295, no. 5, pp. L780–L788, 2008. View at Publisher · View at Google Scholar
  141. J. H. Wang, J. L. Devalia, R. J. Sapsford, and R. J. Davies, “Effect of corticosteroids on release of RANTES and sIAM-1 from cultured human bronchial epithelial cells, induced by TNF-α,” European Respiratory Journal, vol. 10, no. 4, pp. 834–840, 1997. View at Google Scholar
  142. N. M. Heller, S. Matsukura, S. N. Georas et al., “Interferon-γ inhibits STAT6 signal transduction and gene expression in human airway epithelial cells,” American Journal of Respiratory Cell and Molecular Biology, vol. 31, no. 5, pp. 573–582, 2004. View at Publisher · View at Google Scholar · View at Scopus
  143. T. Fujisawa, Y. Kato, J. Atsuta et al., “Chemokine production by the BEAS-2B human bronchial epithelial cells: differential regulation of eotaxin, IL-8, and RANTES by TH2- and TH1-derived cytokines,” Journal of Allergy and Clinical Immunology, vol. 105, no. 1, part 1, pp. 126–133, 2000. View at Google Scholar · View at Scopus
  144. L. A. Laitinen, A. Laitinen, and T. Haahtela, “A comparative study of the effects of an inhaled corticosteroid, budesonide, and a β2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel-group controlled trial,” Journal of Allergy and Clinical Immunology, vol. 90, no. 1, pp. 32–42, 1992. View at Google Scholar · View at Scopus
  145. L. P. Wen, K. Madani, J. A. Fahrni, S. R. Duncan, and G. D. Rosen, “Dexamethasone inhibits lung epithelial cell apoptosis induced by IFN-γ and fas,” American Journal of Physiology, vol. 273, no. 5, part 1, pp. L921–L929, 1997. View at Google Scholar · View at Scopus
  146. G. Pelaia, G. Cuda, A. Vatrella et al., “Effects of transforming growth factor-β and budesonide on mitogen-activated protein kinase activation and apoptosis in airway epithelial cells,” American Journal of Respiratory Cell and Molecular Biology, vol. 29, no. 1, pp. 12–18, 2003. View at Publisher · View at Google Scholar · View at Scopus
  147. N. S. Undevia, D. R. Dorscheid, B. A. Marroquin, W. L. Gugliotta, R. Tse, and S. R. White, “Smad and p38-MAPK signaling mediates apoptotic effects of transforming growth factor-β1 in human airway epithelial cells,” American Journal of Physiology, vol. 287, no. 3, pp. L515–L524, 2004. View at Publisher · View at Google Scholar · View at Scopus
  148. D. R. Dorscheid, B. J. Patchell, O. Estrada, B. Marroquin, R. Tse, and S. R. White, “Effects of corticosteroid-induced apoptosis on airway epithelial wound closure in vitro,” American Journal of Physiology, vol. 291, no. 4, pp. L794–L801, 2006. View at Publisher · View at Google Scholar
  149. R. Tse, B. A. Marroquin, D. R. Dorscheid, and S. R. White, “β-adrenergic agonists inhibit corticosteroid-induced apoptosis of airway epithelial cells,” American Journal of Physiology, vol. 285, no. 2 29-2, pp. L393–L404, 2003. View at Google Scholar
  150. J. A. Hirota, T.-L. Hackett, M. D. Inman, and D. A. Knight, “Modeling asthma in mice: what have we learned about the airway epithelium?” American Journal of Respiratory Cell and Molecular Biology, vol. 44, no. 4, pp. 431–438, 2011. View at Publisher · View at Google Scholar
  151. A. Q. Truong-Tran, R. E. Ruffin, P. S. Foster et al., “Altered zinc homeostasis and caspase-3 activity in murine allergic airway inflammation,” American Journal of Respiratory Cell and Molecular Biology, vol. 27, no. 3, pp. 286–296, 2002. View at Google Scholar · View at Scopus
  152. E. R. McFadden Jr., “Hypothesis: exercise-induced asthma as a vascular phenomenon,” The Lancet, vol. 335, no. 8694, pp. 880–882, 1990. View at Google Scholar · View at Scopus
  153. J. Solway, B. M. Pichurko, and E. P. Ingenito, “Breathing pattern affects airway wall temperature during cold air hyperpnea in humans,” American Review of Respiratory Disease, vol. 132, no. 4, pp. 853–857, 1985. View at Google Scholar
  154. T. S. Hallstrand, M. W. Moody, M. M. Wurfel, L. B. Schwartz, W. R. Henderson, and M. L. Aitken, “Inflammatory basis of exercise-induced bronchoconstriction,” American Journal of Respiratory and Critical Care Medicine, vol. 172, no. 6, pp. 679–686, 2005. View at Publisher · View at Google Scholar · View at Scopus
  155. D. Cockcroft and B. Davis, “Direct and indirect challenges in the clinical assessment of asthma,” Annals of Allergy, Asthma and Immunology, vol. 103, no. 5, pp. 363–400, 2009. View at Google Scholar · View at Scopus
  156. K. W. Rundell and J. B. Slee, “Exercise and other indirect challenges to demonstrate asthma or exercise-induced bronchoconstriction in athletes,” Journal of Allergy and Clinical Immunology, vol. 122, no. 2, pp. 238–246, 2008. View at Publisher · View at Google Scholar · View at Scopus
  157. E.-M. Karjalainen, A. Laitinen, M. Sue-Chu, A. Altraja, L. Bjermer, and L. A. Laitinen, “Evidence of airway inflammation and remodeling in ski athletes with and without bronchial hyperresponsiveness to methacholine,” American Journal of Respiratory and Critical Care Medicine, vol. 161, no. 6, pp. 2086–2091, 2000. View at Google Scholar
  158. M. Sue-Chu, E. M. Karjalainen, A. Laitinen, L. Larsson, L. A. Laitinen, and L. Bjermer, “Placebo-controlled study of inhaled budesonide on indices of airway inflammation in bronchoalveolar lavage fluid and bronchial biopsies in cross-country skiers,” Respiration, vol. 67, no. 4, pp. 417–425, 2000. View at Google Scholar · View at Scopus
  159. V. Bougault, J. Turmel, J. St-Laurent, M. Bertrand, and L.-P. Boulet, “Asthma, airway inflammation and epithelial damage in swimmers and cold-air athletes,” European Respiratory Journal, vol. 33, no. 4, pp. 740–746, 2009. View at Publisher · View at Google Scholar
  160. M. R. Bonsignore, G. Morici, L. Riccobono et al., “Airway cells after swimming outdoors or in the sea in nonasthmatic athletes,” Medicine and Science in Sports and Exercise, vol. 35, no. 7, pp. 1146–1152, 2003. View at Google Scholar
  161. L. Chimenti, G. Morici, A. Paternò et al., “Endurance training damages small airway epithelium in mice,” American Journal of Respiratory and Critical Care Medicine, vol. 175, no. 5, pp. 442–449, 2007. View at Publisher · View at Google Scholar
  162. G. Folkerts, W. W. Busse, F. P. Nijkamp, R. Sorkness, and J. E. Gern, “Virus-induced airway hyperresponsiveness and asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 157, no. 6, part 1, pp. 1708–1720, 1998. View at Google Scholar
  163. S. L. Johnston, P. K. Pattemore, G. Sanderson et al., “Community study of role of viral infections in exacerbations of asthma in 9-11 year old children,” British Medical Journal, vol. 310, no. 6989, pp. 1225–1229, 1995. View at Google Scholar · View at Scopus
  164. P. W. Heymann, H. T. Carper, D. D. Murphy et al., “Viral infections in relation to age, atopy, and season of admission among children hospitalized for wheezing,” Journal of Allergy and Clinical Immunology, vol. 114, no. 2, pp. 239–247, 2004. View at Publisher · View at Google Scholar · View at Scopus
  165. R. F. Lemanske Jr., D. J. Jackson, R. E. Gangnon et al., “Rhinovirus illnesses during infancy predict subsequent childhood wheezing,” Journal of Allergy and Clinical Immunology, vol. 116, no. 3, pp. 571–577, 2005. View at Publisher · View at Google Scholar
  166. S. Hoffjan, D. Nicolae, I. Ostrovnaya et al., “Gene-environment interaction effects on the development of immune responses in the 1st year of life,” American Journal of Human Genetics, vol. 76, no. 4, pp. 696–704, 2005. View at Publisher · View at Google Scholar · View at Scopus
  167. J. E. Gern, L. A. Rosenthal, R. L. Sorkness, and R. F. Lemanske Jr., “Effects of viral respiratory infections on lung development and childhood asthma,” Journal of Allergy and Clinical Immunology, vol. 115, no. 4, pp. 668–674, 2005. View at Publisher · View at Google Scholar
  168. K. Malmström, A. Pitkäranta, O. Carpen et al., “Human rhinovirus in bronchial epithelium of infants with recurrent respiratory symptoms,” Journal of Allergy and Clinical Immunology, vol. 118, no. 3, pp. 591–596, 2006. View at Publisher · View at Google Scholar
  169. S. Kristjansson, S. P. Bjarnarson, G. Wennergren et al., “Respiratory syncytial virus and other respiratory viruses during the first 3 months of life promote a local TH2-like response,” Journal of Allergy and Clinical Immunology, vol. 116, no. 4, pp. 805–811, 2005. View at Publisher · View at Google Scholar · View at Scopus
  170. A. Dakhama, J. W. Park, C. Taube et al., “The enhancement or prevention of airway hyperresponsiveness during reinfection with respiratory syncytial virus is critically dependent on the age at first infection and IL-13 production,” Journal of Immunology, vol. 175, no. 3, pp. 1876–1883, 2005. View at Google Scholar · View at Scopus
  171. V. Kaminskyy and B. Zhivotovsky, “To kill or be killed: how viruses interact with the cell death machinery: symposium,” Journal of Internal Medicine, vol. 267, no. 5, pp. 473–482, 2010. View at Publisher · View at Google Scholar · View at Scopus
  172. A. Kotelkin, E. A. Prikhod'ko, J. I. Cohen, P. L. Collins, and A. Bukreyev, “Respiratory syncytial virus infection sensitizes cells to apoptosis mediated by tumor necrosis factor-related apoptosis-inducing ligand,” Journal of Virology, vol. 77, no. 17, pp. 9156–9172, 2003. View at Publisher · View at Google Scholar
  173. S. Othumpangat, L. F. Gibson, L. Samsell, and G. Piedimonte, “NGF is an essential survival factor for bronchial epithelial cells during respiratory syncytial virus infection,” PLoS One, vol. 4, no. 7, Article ID e6444, 2009. View at Publisher · View at Google Scholar · View at Scopus
  174. L. Deszcz, E. Gaudernak, E. Kuechler, and J. Seipelt, “Apoptotic events induced by human rhinovirus infection,” Journal of General Virology, vol. 86, no. 5, pp. 1379–1389, 2005. View at Publisher · View at Google Scholar · View at Scopus
  175. U. Sajjan, Q. Wang, Y. Zhao, D. C. Gruenert, and M. B. Hershenson, “Rhinovirus disrupts the barrier function of polarized airway epithelial cells,” American Journal of Respiratory and Critical Care Medicine, vol. 178, no. 12, pp. 1271–1281, 2008. View at Publisher · View at Google Scholar · View at Scopus
  176. E. W. A. Brydon, H. Smith, and C. Sweet, “Influenza A virus-induced apoptosis in bronchiolar epithelial (NCl-H292) cells limits pro-inflammatory cytokine release,” Journal of General Virology, vol. 84, no. 9, pp. 2389–2400, 2003. View at Publisher · View at Google Scholar · View at Scopus
  177. S. Maruoka, S. Hashimoto, Y. Gon et al., “ASK1 regulates influenza virus infection-induced apoptotic cell death,” Biochemical and Biophysical Research Communications, vol. 307, no. 4, pp. 870–876, 2003. View at Publisher · View at Google Scholar
  178. Z. Xing, R. Harper, J. Anunciacion et al., “Host immune and apoptotic responses to avian influenza virus H9N2 in human tracheobronchial epithelial cells,” American Journal of Respiratory Cell and Molecular Biology, vol. 44, no. 1, pp. 24–33, 2010. View at Publisher · View at Google Scholar
  179. R. W. Y. Chan, K. M. Yuen, W. C. L. Yu et al., “Influenza H5N1 and H1N1 virus replication and innate immune responses in bronchial epithelial cells are influenced by the state of differentiation,” PLoS One, vol. 5, no. 1, Article ID e8713, 2010. View at Publisher · View at Google Scholar · View at Scopus
  180. S. M. Rowe, S. Miller, and E. J. Sorscher, “Cystic fibrosis,” The New England Journal of Medicine, vol. 352, no. 19, pp. 1992–2001, 2005. View at Publisher · View at Google Scholar · View at Scopus
  181. P. B. Davis, “Cystic fibrosis since 1938,” American Journal of Respiratory and Critical Care Medicine, vol. 173, no. 5, pp. 475–482, 2006. View at Publisher · View at Google Scholar · View at Scopus
  182. A. Elizur, C. L. Cannon, and T. W. Ferkol, “Airway inflammation in cystic fibrosis,” Chest, vol. 133, no. 2, pp. 489–495, 2008. View at Publisher · View at Google Scholar · View at Scopus
  183. C. Amsellem, I. Durieu, M.-T. Chambe, S. Peyrol, and Y. Pachéco, “In vitro expression of Fas and CD40 and induction of apoptosis in human cystic fibrosis airway epithelial cells,” Respiratory Medicine, vol. 96, no. 4, pp. 244–249, 2002. View at Publisher · View at Google Scholar
  184. S. Rajan, G. Cacalano, R. Bryan et al., “Pseudomonas aeruginosa induction of apoptosis in respiratory epithelial cells: analysis of the effects of cystic fibrosis transmembrane conductance regulator dysfunction and bacterial virulence factors,” American Journal of Respiratory Cell and Molecular Biology, vol. 23, no. 3, pp. 304–312, 2000. View at Google Scholar
  185. O. Kamdar, W. Le, J. Zhang, A. J. Ghio, G. D. Rosen, and D. Upadhyay, “Air pollution induces enhanced mitochondrial oxidative stress in cystic fibrosis airway epithelium,” FEBS Letters, vol. 582, no. 25-26, pp. 3601–3606, 2008. View at Publisher · View at Google Scholar · View at Scopus
  186. S. Ahmad, A. Ahmad, E. S. Dremina et al., “Bcl-2 suppresses sarcoplasmic/endoplasmic reticulum Ca2+-ATPase expression in cystic fibrosis airways role in oxidant-mediated cell death,” American Journal of Respiratory and Critical Care Medicine, vol. 179, no. 9, pp. 816–826, 2009. View at Publisher · View at Google Scholar
  187. E. S. Dremina, V. S. Sharov, K. Kumar, A. Zaidi, E. K. Michaelis, and C. Schöneich, “Anti-apoptotic protein Bcl-2 interacts with and destabilizes the sarcoplasmic/endoplasmic reticulum Ca2+-ATPase (SERCA),” Biochemical Journal, vol. 383, no. 2, pp. 361–370, 2004. View at Publisher · View at Google Scholar · View at Scopus
  188. M. Zanetti, “Cathelicidins, multifunctional peptides of the innate immunity,” Journal of Leukocyte Biology, vol. 75, no. 1, pp. 39–48, 2004. View at Publisher · View at Google Scholar · View at Scopus
  189. D. M.E. Bowdish, D. J. Davidson, and R. E.W. Hancock, “Immunomodulatory properties of defensins and cathelicidins,” Current Topics in Microbiology and Immunology, vol. 306, pp. 27–66, 2006. View at Google Scholar
  190. R. Bals, D. J. Weiner, R. L. Meegalla, and J. M. Wilson, “Transfer of a cathelicidin peptide antibiotic gene restores bacterial killing in a cystic fibrosis xenograft model,” Journal of Clinical Investigation, vol. 103, no. 8, pp. 1113–1117, 1999. View at Google Scholar · View at Scopus
  191. J. Aarbiou, G. S. Tjabringa, R. M. Verhoosel et al., “Mechanisms of cell death induced by the neutrophil antimicrobial peptides α-defensins and LL-37,” Inflammation Research, vol. 55, no. 3, pp. 119–127, 2006. View at Publisher · View at Google Scholar · View at Scopus
  192. Y. E. Lau, D. M. E. Bowdish, C. Cosseau, R. E. W. Hancock, and D. J. Davidson, “Apoptosis of airway epithelial cells: human serum sensitive induction by the cathelicidin LL-37,” American Journal of Respiratory Cell and Molecular Biology, vol. 34, no. 4, pp. 399–409, 2006. View at Publisher · View at Google Scholar · View at Scopus
  193. P. G. Barlow, P. E. Beaumont, C. Cosseau et al., “The human cathelicidin LL-37 preferentially promotes apoptosis of infected airway epithelium,” American Journal of Respiratory Cell and Molecular Biology, vol. 43, no. 6, pp. 692–702, 2010. View at Publisher · View at Google Scholar · View at Scopus
  194. K. F. Rabe, S. Hurd, A. Anzueto et al., “Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary,” American Journal of Respiratory and Critical Care Medicine, vol. 176, no. 6, pp. 532–555, 2007. View at Publisher · View at Google Scholar · View at Scopus
  195. Y. Kasahara, R. M. Tuder, L. Taraseviciene-Stewart et al., “Inhibition of VEGF receptors causes lung cell apoptosis and emphysema,” Journal of Clinical Investigation, vol. 106, no. 11, pp. 1311–1319, 2000. View at Google Scholar · View at Scopus
  196. Y. Kasahara, R. M. Tuder, C. D. Cool, D. A. Lynch, S. C. Flores, and N. F. Voelkel, “Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema,” American Journal of Respiratory and Critical Care Medicine, vol. 163, no. 3, part 1, pp. 737–744, 2001. View at Google Scholar
  197. J. Majo, H. Ghezzo, and M. G. Cosio, “Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema,” European Respiratory Journal, vol. 17, no. 5, pp. 946–953, 2001. View at Publisher · View at Google Scholar · View at Scopus
  198. N. Yokohori, K. Aoshiba, A. Nagai, and T. Kuriyama, “Increased levels of cell death and proliferation in alveolar wall cells in patients with pulmonary emphysema,” Chest, vol. 125, no. 2, pp. 626–632, 2004. View at Publisher · View at Google Scholar · View at Scopus
  199. J. W. Park, S. W. Ryter, and A. M. K. Choi, “Functional significance of apoptosis in chronic obstructive pulmonary disease,” COPD: Journal of Chronic Obstructive Pulmonary Disease, vol. 4, no. 4, pp. 347–353, 2007. View at Publisher · View at Google Scholar · View at Scopus
  200. M. Korfei, C. Ruppert, P. Mahavadi et al., “Epithelial endoplasmic reticulum stress and apoptosis in sporadic idiopathic pulmonary fibrosis,” American Journal of Respiratory and Critical Care Medicine, vol. 178, no. 8, pp. 838–846, 2008. View at Publisher · View at Google Scholar
  201. S. Hodge, G. Hodge, M. Holmes, and P. N. Reynolds, “Increased airway epithelial and T-cell apoptosis in COPD remains despite smoking cessation,” European Respiratory Journal, vol. 25, no. 3, pp. 447–454, 2005. View at Publisher · View at Google Scholar · View at Scopus
  202. K. Triantaphyllopoulos, F. Hussain, M. Pinart et al., “A model of chronic inflammation and pulmonary emphysema after multiple ozone exposures in mice,” American Journal of Physiology, vol. 300, no. 5, pp. L691–L700, 2011. View at Publisher · View at Google Scholar
  203. M. Siganaki, A. V. Koutsopoulos, E. Neofytou et al., “Deregulation of apoptosis mediators' p53 and bcl2 in lung tissue of COPD patients,” Respiratory Research, vol. 11, p. 46, 2010. View at Publisher · View at Google Scholar
  204. L. Segura-Valdez, A. Pardo, M. Gaxiola, B. D. Uhal, C. Becerril, and M. Selman, “Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD,” Chest, vol. 117, no. 3, pp. 684–694, 2000. View at Google Scholar · View at Scopus
  205. K. Kuwano, “Epithelial cell apoptosis and lung remodeling,” Cellular & Molecular Immunology, vol. 4, no. 6, pp. 419–429, 2007. View at Google Scholar · View at Scopus
  206. W. R. Coward, G. Saini, and G. Jenkins, “The pathogenesis of idiopathic pulmonary fibrosis,” Therapeutic Advances in Respiratory Disease, vol. 4, no. 6, pp. 367–388, 2010. View at Publisher · View at Google Scholar · View at Scopus
  207. K. Kuwano, N. Nakashima, I. Inoshima et al., “Oxidative stress in lung epithelial cells from patients with idiopathic interstitial pneumonias,” European Respiratory Journal, vol. 21, no. 2, pp. 232–240, 2003. View at Publisher · View at Google Scholar · View at Scopus
  208. M. Demedts, J. Behr, R. Buhl et al., “High-dose acetylcysteine in idiopathic pulmonary fibrosis,” The New England Journal of Medicine, vol. 353, no. 21, pp. 2229–2242, 2005. View at Publisher · View at Google Scholar · View at Scopus
  209. G. W. Hunninghake, “Antioxidant therapy for idiopathic pulmonary fibrosis,” The New England Journal of Medicine, vol. 353, no. 21, pp. 2285–2287, 2005. View at Publisher · View at Google Scholar · View at Scopus
  210. M. Plataki, A. V. Koutsopoulos, K. Darivianaki, G. Delides, N. M. Siafakas, and D. Bouros, “Expression of apoptotic and antiapoptotic markers in epithelial cells in idiopathic pulmonary fibrosis,” Chest, vol. 127, no. 1, pp. 266–274, 2005. View at Publisher · View at Google Scholar · View at Scopus
  211. F. Drakopanagiotakis, A. Xifteri, V. Polychronopoulos, and D. Bouros, “Apoptosis in lung injury and fibrosis,” European Respiratory Journal, vol. 32, no. 6, pp. 1631–1638, 2008. View at Publisher · View at Google Scholar · View at Scopus
  212. J. V. Barbas-Filho, M. A. Ferreira, A. Sesso, R. A. Kairalla, C. R.R. Carvalho, and V. L. Capelozzi, “Evidence of type II pneumocyte apoptosis in the pathogenesis of idiopathic pulmonary fibrosis (IFP)/usual interstitial pneumonia (UIP),” Journal of Clinical Pathology, vol. 54, no. 2, pp. 132–138, 2001. View at Publisher · View at Google Scholar
  213. N. Hagimoto, K. Kuwano, H. Miyazaki et al., “Induction of apoptosis and pulmonary fibrosis in mice in response to ligation of Fas antigen,” American Journal of Respiratory Cell and Molecular Biology, vol. 17, no. 3, pp. 272–278, 1997. View at Google Scholar · View at Scopus
  214. T. Maeyama, K. Kuwano, M. Kawasaki et al., “Upregulation of Fas-signalling molecules in lung epithelial cells from patients with idiopathic pulmonary fibrosis,” European Respiratory Journal, vol. 17, no. 2, pp. 180–189, 2001. View at Publisher · View at Google Scholar · View at Scopus
  215. K. Kuwano, N. Hagimoto, M. Kawasaki et al., “Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis,” Journal of Clinical Investigation, vol. 104, no. 1, pp. 13–19, 1999. View at Google Scholar
  216. T. Jinta, Y. Miyazaki, M. Kishi et al., “The pathogenesis of chronic hypersensitivity pneumonitis in common with idiopathic pulmonary fibrosis: expression of apoptotic markers,” American Journal of Clinical Pathology, vol. 134, no. 4, pp. 613–620, 2010. View at Publisher · View at Google Scholar
  217. K. Kuwano, R. Kunitake, M. Kawasaki et al., “P21Waf1/Cip1/Sdi1 and p53 expression in association with DNA strand breaks in idiopathic pulmonary fibrosis,” American Journal of Respiratory and Critical Care Medicine, vol. 154, no. 2, part 1, pp. 477–483, 1996. View at Google Scholar · View at Scopus
  218. I. Al-Githmi, N. Batawil, N. Shigemura et al., “Bronchiolitis obliterans following lung transplantation,” European Journal of Cardio-Thoracic Surgery, vol. 30, no. 6, pp. 846–851, 2006. View at Publisher · View at Google Scholar · View at Scopus
  219. B. Whitehead, P. Rees, K. Sorensen et al., “Incidence of obliterative bronchiolitis after heart-lung transplantation in children,” Journal of Heart and Lung Transplantation, vol. 12, no. 6, part 1, pp. 903–908, 1993. View at Google Scholar · View at Scopus
  220. T. P. M. Whelan and M. I. Hertz, “Allograft rejection after lung transplantation,” Clinics in Chest Medicine, vol. 26, no. 4, pp. 599–612, 2005. View at Publisher · View at Google Scholar · View at Scopus
  221. J. D. Christie, L. B. Edwards, P. Aurora et al., “Registry of the International Society for Heart and Lung Transplantation: twenty-fifth official adult lung and heart/lung transplantation report—2008,” Journal of Heart and Lung Transplantation, vol. 27, no. 9, pp. 957–969, 2008. View at Publisher · View at Google Scholar · View at Scopus
  222. P. T. Walsh, T. B. Strom, and L. A. Turka, “Routes to transplant tolerance versus rejection: the role of cytokines,” Immunity, vol. 20, no. 2, pp. 121–131, 2004. View at Publisher · View at Google Scholar · View at Scopus
  223. T. Fehr and M. Sykes, “Tolerance induction in clinical transplantation,” Transplant Immunology, vol. 13, no. 2, pp. 117–130, 2004. View at Publisher · View at Google Scholar
  224. A. Jaramillo, B. Naziruddin, L. Zhang et al., “Activation of human airway epithelial cells by non-HLA antibodies developed after lung transplantation: a potential etiological factor for bronchiolitis obliterans syndrome,” Transplantation, vol. 71, no. 7, pp. 966–976, 2001. View at Google Scholar · View at Scopus
  225. A. Jaramillo, C. R. Smith, T. Maruyama, L. Zhang, G. A. Patterson, and T. Mohanakumar, “Anti-HLA class I antibody binding to airway epithelial cells induces production of fibrogenic growth factors and apoptotic cell death: a possible mechanism for bronchiolitis obliterans syndrome,” Human Immunology, vol. 64, no. 5, pp. 521–529, 2003. View at Publisher · View at Google Scholar · View at Scopus
  226. A. Jaramillo, L. Zhang, and T. Mohanakumar, “Binding of anti-HLA class I antibodies to airway epithelial cells induces activation and growth factor production and indirectly upregulates lung fibroblast proliferation,” The Journal of Heart and Lung Transplantation, vol. 20, no. 2, p. 166, 2001. View at Google Scholar
  227. E. M. Shevach, R. S. McHugh, C. A. Piccirillo, and A. M. Thornton, “Control of T-cell activation by CD4+CD25+ suppressor T cells,” Immunological Reviews, vol. 182, pp. 58–67, 2001. View at Publisher · View at Google Scholar · View at Scopus
  228. A. M. Thornton, C. A. Piccirillo, and E. M. Shevach, “Activation requirements for the induction of CD4+CD25+ T cell suppressor function,” European Journal of Immunology, vol. 34, no. 2, pp. 366–376, 2004. View at Publisher · View at Google Scholar · View at Scopus
  229. P. R. Hansen, A. M. Holm, U. G. Svendsen, P. S. Olsen, and C. B. Andersen, “Apoptosis and formation of peroxynitrite in the lungs of patients with obliterative bronchiolitis,” Journal of Heart and Lung Transplantation, vol. 19, no. 2, pp. 160–166, 2000. View at Publisher · View at Google Scholar · View at Scopus
  230. S. Fischer, S. D. Cassivi, A. M. Xavier et al., “Cell death in human lung transplantation: apoptosis induction in human lungs during ischemia and after transplantation,” Annals of Surgery, vol. 231, no. 3, pp. 424–431, 2000. View at Publisher · View at Google Scholar
  231. I. P. Neuringer, R. M. Aris, K. A. Burns, T. L. Bartolotta, W. Chalermskulrat, and S. H. Randell, “Epithelial kinetics in mouse heterotopic tracheal allografts,” American Journal of Transplantation, vol. 2, no. 5, pp. 410–419, 2002. View at Publisher · View at Google Scholar · View at Scopus
  232. H. S. Alho, U. S. Salminen, P. K. Maasilta, P. Pääkkö, and A. L. J. Harjula, “Epithelial apoptosis in experimental obliterative airway disease after lung transplantation,” Journal of Heart and Lung Transplantation, vol. 22, no. 9, pp. 1014–1022, 2003. View at Publisher · View at Google Scholar · View at Scopus
  233. C. Chen, Y. Z. Zhang, H. Zheng, B. B. Xu, and W. Gao, “Suppression of the obliteration process by ventilation in a mouse orthotopic tracheal transplantation model,” Transplantation, vol. 87, no. 12, pp. 1762–1768, 2009. View at Publisher · View at Google Scholar · View at Scopus
  234. E. M. Genden, A. J. Iskander, J. S. Bromberg, and L. Mayer, “Orthotopic tracheal allografts undergo reepithelialization with recipient-derived epithelium,” Archives of Otolaryngology—Head and Neck Surgery, vol. 129, no. 1, pp. 118–123, 2003. View at Google Scholar · View at Scopus
  235. E. Kuo, A. Bharat, J. Shih et al., “Role of airway epithelial injury in murine orthotopic tracheal allograft rejection,” Annals of Thoracic Surgery, vol. 82, no. 4, pp. 1226–1233, 2006. View at Publisher · View at Google Scholar · View at Scopus
  236. F. G. Fernández, A. Jaramillo, C. Chen et al., “Airway epithelium is the primary target of allograft rejection in murine obliterative airway disease,” American Journal of Transplantation, vol. 4, no. 3, pp. 319–325, 2004. View at Publisher · View at Google Scholar · View at Scopus
  237. M. J. Shaw, H. Shennib, L. Tayara, E. Ohlstein, and A. Giaid, “Endothelin receptor antagonist SB209670 decreases lung allograft apoptosis and improves lung graft function after prolonged ischemia,” Journal of Cardiovascular Pharmacology, vol. 36, no. 5, supplement 1, pp. S209–S211, 2000. View at Publisher · View at Google Scholar
  238. S. Jesmin, S. Zaedi, N. Yamaguchi et al., “Effects of dual endothelin receptor antagonist on antiapoptotic marker Bcl-2 expression in streptozotocin-induced diabetic rats,” Experimental Biology and Medicine, vol. 231, no. 6, pp. 1034–1039, 2006. View at Google Scholar
  239. H. Jyonouchi, S. Sun, K. Iijima, M. Wang, and S. S. Hecht, “Effects of anti-7,8-dihydroxy-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene on human small airway epithelial cells and the protective effects of myo-inositol,” Carcinogenesis, vol. 20, no. 1, pp. 139–145, 1999. View at Publisher · View at Google Scholar · View at Scopus
  240. H. Jyonouchi, S. Sun, V. A. Porter, and D. N. Cornfield, “Polycyclic aromatic hydrocarbon diol epoxides increase cytosolic Ca2+ of airway epithelial cells,” American Journal of Respiratory Cell and Molecular Biology, vol. 25, no. 1, pp. 78–83, 2001. View at Google Scholar · View at Scopus
  241. Z. Dagher, G. Garçon, S. Billet et al., “Activation of different pathways of apoptosis by air pollution particulate matter (PM2.5) in human epithelial lung cells (L132) in culture,” Toxicology, vol. 225, no. 1, pp. 12–24, 2006. View at Publisher · View at Google Scholar · View at Scopus
  242. I. Ferecatu, M.-C. Borot, C. Bossard et al., “Polycyclic aromatic hydrocarbon components contribute to the mitochondria-antiapoptotic effect of fine particulate matter on human bronchial epithelial cells via the aryl hydrocarbon receptor,” Particle and Fibre Toxicology, vol. 7, article 18, 2010. View at Publisher · View at Google Scholar
  243. M. Rumelhard, K. Ramgolam, R. Hamel, F. Marano, and A. Baeza-Squiban, “Expression and role of EGFR ligands induced in airway cells by PM2.5 and its components,” European Respiratory Journal, vol. 30, no. 6, pp. 1064–1073, 2007. View at Publisher · View at Google Scholar · View at Scopus
  244. A. Baulig, S. Singh, A. Marchand et al., “Role of Paris PM2.5 components in the pro-inflammatory response induced in airway epithelial cells,” Toxicology, vol. 261, no. 3, pp. 126–135, 2009. View at Publisher · View at Google Scholar · View at Scopus
  245. C. Karacsonyi, N. Shanmugam, and E. Kagan, “A clinically relevant in vitro model for evaluating the effects of aerosolized vesicants,” Toxicology Letters, vol. 185, no. 1, pp. 38–44, 2009. View at Publisher · View at Google Scholar